JP2014517825A5 - - Google Patents

Download PDF

Info

Publication number
JP2014517825A5
JP2014517825A5 JP2014506585A JP2014506585A JP2014517825A5 JP 2014517825 A5 JP2014517825 A5 JP 2014517825A5 JP 2014506585 A JP2014506585 A JP 2014506585A JP 2014506585 A JP2014506585 A JP 2014506585A JP 2014517825 A5 JP2014517825 A5 JP 2014517825A5
Authority
JP
Japan
Prior art keywords
use according
seconds
microprojection
contact
hpthrp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014517825A (ja
JP6033280B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/034510 external-priority patent/WO2012145665A2/en
Publication of JP2014517825A publication Critical patent/JP2014517825A/ja
Publication of JP2014517825A5 publication Critical patent/JP2014517825A5/ja
Application granted granted Critical
Publication of JP6033280B2 publication Critical patent/JP6033280B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506585A 2011-04-22 2012-04-20 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法 Expired - Fee Related JP6033280B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161478466P 2011-04-22 2011-04-22
US61/478,466 2011-04-22
US201161578120P 2011-12-20 2011-12-20
US61/578,120 2011-12-20
PCT/US2012/034510 WO2012145665A2 (en) 2011-04-22 2012-04-20 Method of drug delivery for pth, pthrp and related peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016208896A Division JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Publications (3)

Publication Number Publication Date
JP2014517825A JP2014517825A (ja) 2014-07-24
JP2014517825A5 true JP2014517825A5 (enExample) 2015-06-11
JP6033280B2 JP6033280B2 (ja) 2016-11-30

Family

ID=47042187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014506585A Expired - Fee Related JP6033280B2 (ja) 2011-04-22 2012-04-20 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法
JP2016208896A Pending JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016208896A Pending JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Country Status (14)

Country Link
US (6) US20130006217A1 (enExample)
EP (2) EP2699252B1 (enExample)
JP (2) JP6033280B2 (enExample)
KR (1) KR20140047043A (enExample)
CN (1) CN103917242A (enExample)
AU (2) AU2012245301B2 (enExample)
BR (1) BR112013027153A2 (enExample)
CA (1) CA2833571A1 (enExample)
ES (1) ES2648864T3 (enExample)
IL (1) IL228942A0 (enExample)
MX (1) MX2013012349A (enExample)
RU (1) RU2013151314A (enExample)
SG (1) SG194570A1 (enExample)
WO (1) WO2012145665A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
US20130158482A1 (en) * 2010-07-26 2013-06-20 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
EP2637562B1 (en) 2010-11-09 2016-01-27 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
AU2012345768B2 (en) * 2011-11-30 2016-05-12 Kindeva Drug Delivery L.P. Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
HK1209657A1 (en) * 2012-08-30 2016-04-08 Teijin Limited Microneedle array coated with drug composition
RS67458B1 (sr) 2014-03-28 2025-12-31 Univ Duke Lečenje kancera dojke pozitivnog na receptor estrogena upotrebom selektivnih modulatora receptora estrogena
WO2016141250A1 (en) * 2015-03-03 2016-09-09 Radius Health, Inc. USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
KR102676629B1 (ko) 2015-04-29 2024-06-18 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
WO2017007777A2 (en) * 2015-07-06 2017-01-12 Zhengxin Dong NOVEL FORMULATIONS OF PTHrP ANALOGUE
BR112018007159A2 (pt) * 2015-10-09 2018-11-06 3M Innovative Properties Co formulações de análogos de pthrp, emplastros transdérmicos dos mesmos e usos dos mesmos
ES2909043T3 (es) 2015-10-09 2022-05-05 Kindeva Drug Delivery Lp Composiciones de zinc para sistemas de microagujas recubiertos
CA3020333A1 (en) * 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
RS63311B1 (sr) 2016-06-22 2022-07-29 Ellipses Pharma Ltd Ar+ metode lečenja raka dojke
BR112019011070A2 (pt) * 2016-11-30 2019-10-01 Purdue Research Foundation regeneração óssea direcionada à fratura através da estimulação do receptor de hormônio da paratireoide
KR102881465B1 (ko) 2017-01-05 2025-11-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
US9968767B1 (en) 2017-10-10 2018-05-15 King Saud University Combination microarray patch for drug delivery and electrochemotherapy device
EP3790574A4 (en) 2018-05-30 2022-07-13 Purdue Research Foundation TARGETING ANABOLIC DRUGS TO ACCELERATE FRACTURE REPAIR
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
JOP20210218A1 (ar) 2019-02-12 2023-01-30 Radius Pharmaceuticals Inc عمليات ومركبات
WO2021149012A1 (en) 2020-01-24 2021-07-29 Radius Health, Inc. Methods of stimulating bone growth with abalopartide and denosumab
BR112022022039A2 (pt) 2020-04-28 2022-12-13 Ticona Llc Conjunto de microagulhas
EP4142693A1 (en) * 2020-05-01 2023-03-08 Emergex USA Corporation Transdermal drug delivery devices having psilocybin, lysergic acid diethylamide or 3,4-methylenedioxymethamphetamine coated microprotrusions
WO2022149066A1 (en) * 2021-01-05 2022-07-14 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
PT1037686E (pt) * 1997-12-11 2005-10-31 Alza Corp Aparelho para potenciar o fluxo de agente transdermico
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
GB9930882D0 (en) * 1999-12-30 2000-02-23 Nps Allelix Corp GLP-2 formulations
KR20070001886A (ko) * 2003-10-28 2007-01-04 알자 코포레이션 치료용 펩타이드 및 단백질의 폴리머 컨쥬게이트의 피복된미세돌출부를 통한 전달
US7097631B2 (en) * 2003-10-31 2006-08-29 Alza Corporation Self-actuating applicator for microprojection array
BRPI0416042A (pt) * 2003-11-13 2007-01-02 Alza Corp composição e aparelho para suprimento transdérmico
JP5007427B2 (ja) 2004-05-13 2012-08-22 アルザ コーポレイション 副甲状腺ホルモン剤の経皮送達のための装置および方法
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
JP2009522288A (ja) * 2005-12-28 2009-06-11 アルザ コーポレイション 安定な治療剤形
CN101466393A (zh) * 2006-03-15 2009-06-24 阿尔扎公司 用于经皮递送甲状旁腺激素药剂以治疗骨质减少的方法
WO2007124411A1 (en) 2006-04-20 2007-11-01 3M Innovative Properties Company Device for applying a microneedle array
WO2007124409A2 (en) * 2006-04-20 2007-11-01 Velocys, Inc. Process for treating and/or forming a non-newtonian fluid using microchannel process technology
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CA2664734C (en) 2006-10-03 2023-08-01 Radius Health, Inc. Method of drug delivery for bone anabolic protein
JP5241517B2 (ja) * 2007-02-06 2013-07-17 久光製薬株式会社 アレルギー診断用マイクロニードルデバイス
JP5559054B2 (ja) * 2007-09-28 2014-07-23 ザ クイーンズ ユニヴァーシティ オブ ベルファスト 送達装置および方法
WO2009054988A1 (en) * 2007-10-23 2009-04-30 Alza Corporation Transdermal sustained release drug delivery
EP2052736A1 (en) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroid hormone formulations und uses thereof
US8329649B2 (en) 2008-11-04 2012-12-11 Aska Pharmaceutical Co., Ltd. Aqueous composition containing follicle-stimulating hormone and histidine
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device

Similar Documents

Publication Publication Date Title
Weinstein Glucocorticoid‐induced bone disease
Wakabayashi et al. Comprehensive approach to sarcopenia treatment
JP6033280B2 (ja) ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法
AU2012245301A1 (en) Method of drug delivery for PTH, PTHrP and related peptides
JP2014530242A (ja) 皮膚疾病の処置用のケメリンｃ１５ペプチドの局所製剤
Ahmed et al. Effect of 1.5% topical diclofenac on clinical neuropathic pain
Holm et al. Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide
Harada et al. Effect of alendronate on muscle mass: investigation in patients with osteoporosis
Piscitelli et al. Alendronate: new formulations of an old and effective drug to improve adherence avoiding upper gastrointestinal side effects.
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
JP2018508488A (ja) Ｓｐｉｒａｎｔｈｅｓ ｓｉｎｅｎｓｉｓ抽出物を含有する組成物およびその薬学的適用
Avioli Calcitonin therapy in osteoporotic syndromes
Mazziotti et al. Treatment of glucocorticoid-induced osteoporosis
ES2425095T3 (es) Método de tratamiento de la fragilidad
RU2637401C1 (ru) Способ профилактики отдаленных послеоперационных осложнений у больных с дисплазией соединительной ткани
US20230330191A1 (en) Methods of stimulating bone growth with abaloparatide and denosumab
Park et al. Fixation of the femoral subtrochanteric fracture with minimally invasive reduction techniques
Jarusriwanna et al. A randomized trial comparing efficacy and safety of brand versus generic alendronate for osteoporosis treatment
Wang et al. Effect of anti-osteoporotic drugs in reducing risk of refracture after percutaneous vertebroplasty
Khuangsirikul et al. Effect of Transdermal Microneedle Patch with NSAID in Osteoarthritic Knee: A Randomized Controlled Trial
Hao et al. Effects Of Beta-hydroxy-beta-methylbutyrate On Markers Of Muscle Hypertrophy And Apoptotic Signaling During Reloading In Aged Rats Following Disuse: 592: June 2 10: 30 AM-10: 45 AM
Donnelly et al. Severe allergic reaction following histrelin implant (supprelin la)
Seeman et al. Zoledronic Acid Substantially Reduces the Risk of Morphometric Vertebral and Clinical Fractures
Lee Bone health in the treatment of postmenopausal women with Aromatase Inhibitors and premenopausal women treated with ovarian suppression and Aromatase inhibitors: a hands-on guide
Schafer et al. Novel Osteoporosis Therapies